iCanWork: A Randomized Controlled Trial
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorMcGill University
About this trial
The aim of this study is to evaluate the effectiveness of the iCanWork intervention in assisting cancer survivors (CS) to return to work (RTW) and its impact on their health-related quality of life (QoL), health service utilization, RTW readiness, time to RTW, and work capacity.
Eligibility criteria
Qualifiers
diagnosed with cancer (all types) treated with curative intent and of working age (between 18 and 65 at the time of diagnosis)
gainfully employed at the time of diagnosis (full or part-time, including students)
still on sick leave, including long-term disability leave, but for less than 2 years
has not started to return to work, since stopping due to cancer
Disqualifiers
None
Trial design
Treatments tested in this trial
- iCanWork Intervention
Treatment groups
270 Participants
are divided into 2 treatment groupsLocations
1McGill UniversityH3A 0G4, MontrealQuebec, Canada
Sponsors and collaborators
McGill University
Lead sponsor
Source ClinicalTrials.gov